Metabolic syndrome (MBS), also known as insulin resistance syndrome, is a collection of disorders characterized by abdominal obesity, high blood pressure, high blood sugar, high serum triglyceride levels, and low high-density lipoprotein levels. In tandem with the worldwide growth in obesity, the prevalence of MBS has increased quickly. Globally, it is a leading cause of morbidity and mortality with a sizeable socioeconomic impact.
Metabolic syndrome (MBS) is a clustering of at least three medical conditions: abdominal obesity, high blood pressure, high blood sugar, high serum triglycerides, and low high-density lipoprotein (HDL) values.
Metabolic syndrome (MBS), also known as syndrome X or insulin resistance syndrome, is a cluster of at least three medical conditions: abdominal obesity, high blood pressure, high blood sugar, elevated serum triglyceride levels, and low high-density lipoprotein (HDL) values. It is frequently accompanied by type 2 diabetes mellitus and cardiovascular illnesses such as coronary artery disease (CAD).
National Institutes of Health: "Metabolic syndrome is a cluster of metabolic risk factors, including abdominal obesity, hypertension, hypertriglyceridemia, low HDL cholesterol, and increased fasting glucose or type 2 diabetes." These risk factors contribute to insulin resistance in skeletal muscle. Insulin resistance is characterized by impaired glucose transport into muscle cells, which causes blood glucose levels to rise due to an excess of glucose in the bloodstream. In addition, as this condition has been linked to an increase in the generation of reactive oxygen species (ROS), it may contribute to cell damage through oxidative stress processes.
MBS raises the likelihood of getting cardiovascular disease and type 2 diabetes.
There is evidence that metabolic syndrome (MS) increases the risk of developing cardiovascular disease and type 2 diabetes. A recent meta-analysis estimated that 20 and 30 percent of patients with MBS develop these diseases throughout their lives, compared to 5 to 10 percent without the syndrome.
In tandem with the worldwide growth in obesity, the prevalence of MBS has increased quickly.
The United States has the highest prevalence of metabolic syndrome worldwide, even though its prevalence has increased globally alongside the rise in obesity. According to reports, almost fifty percent of adults have at least three risk factors for MBS.
Globally, it is a leading cause of morbidity and mortality with a sizeable socioeconomic impact.
Globally, metabolic syndrome is a leading cause of disease and mortality that imposes a substantial socioeconomic burden. It is characterized by a cluster of cardiovascular risk factors, such as obesity, glucose intolerance, dyslipidemia, insulin resistance, and high blood pressure. In India, the prevalence of metabolic syndrome has increased rapidly over the past decade, affecting more than 30 percent of the population older than 25.
Metabolic Syndrome is responsible for 5 to 10 percent of all deaths in the general population, which equates to one million deaths each year across the globe. The economic burden of medical care expenditures associated with cardiovascular diseases (CVD) linked to metabolic syndrome was estimated to be $324 billion in 2008 US dollars using WHO methodology and prevalence statistics from 2009 published by International Diabetes Federation (IDF).
In a study undertaken to determine the efficacy of lifestyle adjustment in MS patients, 93% of patients obtained a healthy body weight (80%) and an improved lipid profile.
A study was done to investigate the efficacy of lifestyle adjustment in people with multiple sclerosis. Body mass index, lipid profile, and quality of life were outcome measures (QOL). This prospective, single-blind study included 40 patients with MS (aged 18 or older) randomly divided into two groups: the control group received conventional treatment without any lifestyle changes. In contrast, the experimental group received traditional treatment plus dietary management and exercise training for 12 weeks. To compare group means at baseline and follow-up, an independent t-test was utilized. The baseline and 12-week follow-up data for each group were compared using a paired-samplest-test. The outcome was:
At baseline, mean age, BMI (kg/m2), waist circumference (cm), and triglyceride levels were significantly higher than ideal in both groups;
In the experimental group, after a 12-week intervention diet and exercise training program, the mean values of all parameters except HDL cholesterol were unaltered.
In the control group, after 12 weeks of dieting alone, only systolic blood pressure improved significantly, although BMI, waist circumference, and other indicators did not;
Most cases of metabolic syndrome are avoidable via lifestyle modifications, including diet and exercise.
Changes in diet and lifestyle can prevent or delay the onset of metabolic syndrome.
Choose a healthy eating plan that delivers the appropriate quantity of calories, nutrients, and liquids to help you maintain a healthy weight. These foods contribute to an unhealthy diet; you should avoid them.
Participate in at least 30 minutes of aerobic activity on most weekdays. Also, twice a week, perform weight training activities to develop your muscles to utilize energy more efficiently.
Some patients diagnosed with metabolic syndrome may require dietary adjustments.
Some patients diagnosed with metabolic syndrome may require dietary adjustments. Dietary adjustments may include a low-fat, low-glycemic, or Mediterranean diet.
Modifications to a patient's diet should be customized to their specific demands and preferences.
Some things can be done to reverse metabolic syndrome, which is good news. The initial step is to see a doctor and get tested for the condition, which includes examining your blood pressure, blood sugar, blood fat levels (triglycerides), and body weight. Then they will assist you in developing a long-term management strategy. If necessary, they may prescribe medications or recommend lifestyle modifications, such as dietary changes or exercise routines, explicitly designed for patients with metabolic syndrome."